Lipocine
LPCN
LPCN
33 hedge funds and large institutions have $11.5M invested in Lipocine in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 29 → 33 (+4)
0.12% more ownership
Funds ownership: 0.64% → 0.76% (+0.12%)
Holders
33
Holding in Top 10
–
Calls
$723K
Puts
$23K
Top Buyers
| 1 | +$861K | |
| 2 | +$453K | |
| 3 | +$283K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$204K |
| 5 |
AC
Aristides Capital
Louisville,
Kentucky
|
+$199K |
Top Sellers
| 1 | -$625K | |
| 2 | -$253K | |
| 3 | -$72.1K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$37K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$37K |